Market Cap 22.74B
Revenue (ttm) 3.18B
Net Income (ttm) 1.33B
EPS (ttm) N/A
PE Ratio 19.53
Forward PE 19.87
Profit Margin 41.94%
Debt to Equity Ratio 0.00
Volume 318,800
Avg Vol 498,910
Day's Range N/A - N/A
Shares Out 42.45M
Stochastic %K 22%
Beta 0.58
Analysts Strong Sell
Price Target $665.64

Company Profile

United Therapeutics Corporation engages in the development and commercialization of products to address the unmet medical needs of patients with chronic and life-threatening diseases in the United States and internationally. It offers Tyvaso DPI, an inhaled dry powder via pre-filled and single-use cartridges; Nebulized Tyvaso, an inhaled solution via ultrasonic nebulizer; Remodulin (treprostinil) injection to treat patients with pulmonary arterial hypertension to diminish symptoms associated wit...

Industry: Drug Manufacturers - Specialty & Generic
Sector: Healthcare
Phone: 301 608 9292
Address:
1000 Spring Street, Silver Spring, United States
clan
clan Jul. 17 at 2:54 PM
$MNKD $UTHR $SPY 🚨 💲Ralinepag DPI = BLOCKBUSTER potential! 💲 • Progressive Pulmonary Fibrosis & • Idiopathic Pulmonary Fibrosis & • Pulmonary Arterial Hypertension & • Pulmonary Hypertension Associated With Interstitial Lung Disease
0 · Reply
VJLer
VJLer Jul. 16 at 4:11 PM
$DDD If anyone has their doubts about 3D look at the SEC filings that show (for the Q ended March 31, 2026) that they generated $95.5 MM of revenue and negative EBITDA of about $1.5 MM. Balance sheet at 3/31/26 shows cash of $85.1 MM (net cash of negative $4.0 MM or so) which was before the raise. And look at all the incredible initiatives that they have in Healthcare (including working with $UTHR on an artificial lung), dental, industrial, defense, work internationally. Don't rely on anyone's postings until you have read all the repository of data that tell a fantastic story of a company that has incredible upside and a fantastic risk/reward scenario. I bet it closed green today.
2 · Reply
Bazziggr
Bazziggr Jul. 14 at 3:21 PM
0 · Reply
clan
clan Jul. 13 at 11:40 PM
$MNKD $UTHR $BX Another FDA approval incoming! For the good of all Mannkind. $SPY
0 · Reply
clan
clan Jul. 13 at 9:31 PM
$MNKD 10B4YE 10B4TurkeyDay🦃🌽🥧 $UTHR $BX $CIPLA.NSE
0 · Reply
biotech_sellout
biotech_sellout Jul. 13 at 1:39 PM
@Kuka I understand your point but I think you are reading a bit too much into that very superficial, if not irrelevant, "watcher" metric. You have mentioned institutional buyer percentage in the past. According to Marketbeat's info, $MNKD https://www.marketbeat.com/stocks/NASDAQ/UTHR/institutional-ownership/ has a current institutional ownership of ~49% with 141 institutions buying over the last 12 months. On the other hand, $UTHR https://www.marketbeat.com/stocks/NASDAQ/UTHR/institutional-ownership/ has an institutional ownership rate at an astounding 94% with 576 institutions buying over the last 12 months. I think that metric tells us a bit more about how what investors truly think about each stock.
4 · Reply
grampslol
grampslol Jul. 11 at 7:44 AM
$MNKD watch out $UTHR $MRK $AMGN $NVS here's another week of afrezza dpi inhaled prandial insulin approved in 2014 scripts ... wk ending 7/3/26 New 328 refills 461 .... Lol
1 · Reply
clan
clan Jul. 11 at 6:25 AM
$UTHR subsequently paid a $5 million collaboration and development support payment to MannKind {$0.016/sh} in April 2026 [2Q26; to be reported on in 3 weeks]. $35M {$0.11/share} more to come $MNKD 's way. # Partners for life ... more humann❗️ � ​👀 $NVS $MRK $AMGN
1 · Reply
clan
clan Jul. 10 at 10:48 PM
$MNKD $UTHR @ItzaFugazi [insert sarcasm] Unither was so ready to transition off of DPI, that they are spending millions on developing multi-billion dollar potential Ralinepag in a DPI formulation (with Mannkind). #makeitmakesense #technosphere 10% for the big guy. Update on outlook is incoming.
1 · Reply
clan
clan Jul. 10 at 12:10 PM
$MNKD 💵🌳 #mannkind $CIPLA.NSE $BX $UTHR
0 · Reply
Latest News on UTHR
United Therapeutics acquires Thymmune Therapeutics

2026-07-02T10:35:12.000Z - 18 days ago

United Therapeutics acquires Thymmune Therapeutics


United Therapeutics Transcript: AGM 2026

Jun 26, 2026, 10:30 AM EDT - 24 days ago

United Therapeutics Transcript: AGM 2026


United Therapeutics says TETON-1 study published in NEJM

2026-05-18T20:21:29.000Z - 2 months ago

United Therapeutics says TETON-1 study published in NEJM


United Therapeutics reports Q1 EPS $5.82, consensus $6.86

2026-05-07T09:22:42.000Z - 2 months ago

United Therapeutics reports Q1 EPS $5.82, consensus $6.86


United Therapeutics reports Q1 EPS $5.82, consensus $6.86

2026-05-07T09:21:34.000Z - 2 months ago

United Therapeutics reports Q1 EPS $5.82, consensus $6.86


United Therapeutics Earnings Call Transcript: Q1 2026

May 6, 2026, 9:00 AM EDT - 2 months ago

United Therapeutics Earnings Call Transcript: Q1 2026


United Therapeutics Quarterly report: Q1 2026

May 6, 2026, 9:00 AM EDT - 2 months ago

United Therapeutics Quarterly report: Q1 2026


United Therapeutics Earnings release: Q1 2026

May 6, 2026, 9:00 AM EDT - 2 months ago

United Therapeutics Earnings release: Q1 2026


United Therapeutics Slides: Q1 2026

May 6, 2026, 9:00 AM EDT - 2 months ago

United Therapeutics Slides: Q1 2026


United Therapeutics Proxy statement: Proxy filing

Apr 29, 2026, 8:00 AM EDT - 2 months ago

United Therapeutics Proxy statement: Proxy filing


United Therapeutics Proxy statement: Proxy filing

Apr 29, 2026, 8:00 AM EDT - 2 months ago

United Therapeutics Proxy statement: Proxy filing


United Therapeutics Transcript: Study result

Mar 2, 2026, 8:30 AM EST - 5 months ago

United Therapeutics Transcript: Study result


United Therapeutics Press release: Study result

Mar 2, 2026, 8:30 AM EST - 5 months ago

United Therapeutics Press release: Study result


United Therapeutics Slides: Study result

Mar 2, 2026, 8:30 AM EST - 5 months ago

United Therapeutics Slides: Study result


United Therapeutics Earnings Call Transcript: Q4 2025

Feb 25, 2026, 9:00 AM EST - 5 months ago

United Therapeutics Earnings Call Transcript: Q4 2025


United Therapeutics Earnings release: Q4 2025

Feb 25, 2026, 9:00 AM EST - 5 months ago

United Therapeutics Earnings release: Q4 2025


United Therapeutics Annual report: Q4 2025

Feb 25, 2026, 9:00 AM EST - 5 months ago

United Therapeutics Annual report: Q4 2025


United Therapeutics Slides: Q4 2025

Feb 25, 2026, 9:00 AM EST - 5 months ago

United Therapeutics Slides: Q4 2025


Flurry of Bullish Inflows Sends United Therapeutics Higher

Dec 3, 2025, 7:19 AM EST - 8 months ago

Flurry of Bullish Inflows Sends United Therapeutics Higher


United Therapeutics Earnings Call Transcript: Q3 2025

Oct 29, 2025, 9:00 AM EDT - 9 months ago

United Therapeutics Earnings Call Transcript: Q3 2025


United Therapeutics Earnings release: Q3 2025

Oct 29, 2025, 9:00 AM EDT - 9 months ago

United Therapeutics Earnings release: Q3 2025


United Therapeutics Quarterly report: Q3 2025

Oct 29, 2025, 9:00 AM EDT - 9 months ago

United Therapeutics Quarterly report: Q3 2025


United Therapeutics Slides: Q3 2025

Oct 29, 2025, 9:00 AM EDT - 9 months ago

United Therapeutics Slides: Q3 2025


United Therapeutics Transcript: Study Update

Sep 28, 2025, 12:30 PM EDT - 10 months ago

United Therapeutics Transcript: Study Update


United Therapeutics Press release: Study Update

Sep 28, 2025, 12:30 PM EDT - 10 months ago

United Therapeutics Press release: Study Update


United Therapeutics Slides: Study Update

Sep 28, 2025, 12:30 PM EDT - 10 months ago

United Therapeutics Slides: Study Update


United Therapeutics: Is UTHR Stock Still A Buy At $400?

Sep 3, 2025, 10:10 AM EDT - 11 months ago

United Therapeutics: Is UTHR Stock Still A Buy At $400?


United Therapeutics Earnings Call Transcript: Q2 2025

Jul 30, 2025, 9:00 AM EDT - 1 year ago

United Therapeutics Earnings Call Transcript: Q2 2025


United Therapeutics Quarterly report: Q2 2025

Jul 30, 2025, 9:00 AM EDT - 1 year ago

United Therapeutics Quarterly report: Q2 2025


United Therapeutics Earnings release: Q2 2025

Jul 30, 2025, 9:00 AM EDT - 1 year ago

United Therapeutics Earnings release: Q2 2025


United Therapeutics Slides: Q2 2025

Jul 30, 2025, 9:00 AM EDT - 1 year ago

United Therapeutics Slides: Q2 2025


United Therapeutics Earnings Call Transcript: Q1 2025

Apr 30, 2025, 9:00 AM EDT - 1 year ago

United Therapeutics Earnings Call Transcript: Q1 2025


United Therapeutics Earnings release: Q1 2025

Apr 30, 2025, 9:00 AM EDT - 1 year ago

United Therapeutics Earnings release: Q1 2025


United Therapeutics Quarterly report: Q1 2025

Apr 30, 2025, 9:00 AM EDT - 1 year ago

United Therapeutics Quarterly report: Q1 2025


United Therapeutics Slides: Q1 2025

Apr 30, 2025, 9:00 AM EDT - 1 year ago

United Therapeutics Slides: Q1 2025


United Therapeutics Proxy statement: Proxy Filing

Apr 29, 2025, 8:00 AM EDT - 1 year ago

United Therapeutics Proxy statement: Proxy Filing


United Therapeutics Proxy statement: Proxy Filing

Apr 29, 2025, 8:00 AM EDT - 1 year ago

United Therapeutics Proxy statement: Proxy Filing


clan
clan Jul. 17 at 2:54 PM
$MNKD $UTHR $SPY 🚨 💲Ralinepag DPI = BLOCKBUSTER potential! 💲 • Progressive Pulmonary Fibrosis & • Idiopathic Pulmonary Fibrosis & • Pulmonary Arterial Hypertension & • Pulmonary Hypertension Associated With Interstitial Lung Disease
0 · Reply
VJLer
VJLer Jul. 16 at 4:11 PM
$DDD If anyone has their doubts about 3D look at the SEC filings that show (for the Q ended March 31, 2026) that they generated $95.5 MM of revenue and negative EBITDA of about $1.5 MM. Balance sheet at 3/31/26 shows cash of $85.1 MM (net cash of negative $4.0 MM or so) which was before the raise. And look at all the incredible initiatives that they have in Healthcare (including working with $UTHR on an artificial lung), dental, industrial, defense, work internationally. Don't rely on anyone's postings until you have read all the repository of data that tell a fantastic story of a company that has incredible upside and a fantastic risk/reward scenario. I bet it closed green today.
2 · Reply
Bazziggr
Bazziggr Jul. 14 at 3:21 PM
0 · Reply
clan
clan Jul. 13 at 11:40 PM
$MNKD $UTHR $BX Another FDA approval incoming! For the good of all Mannkind. $SPY
0 · Reply
clan
clan Jul. 13 at 9:31 PM
$MNKD 10B4YE 10B4TurkeyDay🦃🌽🥧 $UTHR $BX $CIPLA.NSE
0 · Reply
biotech_sellout
biotech_sellout Jul. 13 at 1:39 PM
@Kuka I understand your point but I think you are reading a bit too much into that very superficial, if not irrelevant, "watcher" metric. You have mentioned institutional buyer percentage in the past. According to Marketbeat's info, $MNKD https://www.marketbeat.com/stocks/NASDAQ/UTHR/institutional-ownership/ has a current institutional ownership of ~49% with 141 institutions buying over the last 12 months. On the other hand, $UTHR https://www.marketbeat.com/stocks/NASDAQ/UTHR/institutional-ownership/ has an institutional ownership rate at an astounding 94% with 576 institutions buying over the last 12 months. I think that metric tells us a bit more about how what investors truly think about each stock.
4 · Reply
grampslol
grampslol Jul. 11 at 7:44 AM
$MNKD watch out $UTHR $MRK $AMGN $NVS here's another week of afrezza dpi inhaled prandial insulin approved in 2014 scripts ... wk ending 7/3/26 New 328 refills 461 .... Lol
1 · Reply
clan
clan Jul. 11 at 6:25 AM
$UTHR subsequently paid a $5 million collaboration and development support payment to MannKind {$0.016/sh} in April 2026 [2Q26; to be reported on in 3 weeks]. $35M {$0.11/share} more to come $MNKD 's way. # Partners for life ... more humann❗️ � ​👀 $NVS $MRK $AMGN
1 · Reply
clan
clan Jul. 10 at 10:48 PM
$MNKD $UTHR @ItzaFugazi [insert sarcasm] Unither was so ready to transition off of DPI, that they are spending millions on developing multi-billion dollar potential Ralinepag in a DPI formulation (with Mannkind). #makeitmakesense #technosphere 10% for the big guy. Update on outlook is incoming.
1 · Reply
clan
clan Jul. 10 at 12:10 PM
$MNKD 💵🌳 #mannkind $CIPLA.NSE $BX $UTHR
0 · Reply
clan
clan Jul. 9 at 5:37 PM
$MNKD $UTHR So there ya have it. The ayes have it. Lung disease. We shall see. Hopefully fully disclosed sooner than later. 🤑
0 · Reply
clan
clan Jul. 9 at 12:58 PM
$MNKD $UTHR I am the undisupted world champion heavyweight grand master Troll Triggerer.🏆 I live rent-free in AffizzledGrampspoo's twisted head.🧌
1 · Reply
clan
clan Jul. 9 at 9:48 AM
$UTHR Did somebody mention a bridge study for IPF and PPF? YUUUUGE! That'll be GREAT for all Mannkind ... and $MNKD #tyvasodpi 10% for the big guy. #technosphere
0 · Reply
Bazziggr
Bazziggr Jul. 7 at 1:07 PM
$UTHR few more
0 · Reply
BillionerOfKing
BillionerOfKing Jul. 7 at 3:55 AM
$UTHR Current Stock Price: $547.22 Contracts to trade: $550.0 UTHR Jul 17 2026 Call Entry: $9.00 Exit: $16.89 ROI: 88% Hold ~23 days Shared as daily free alerts and for educational purposes only. https://dailypickai.com/freealerts
0 · Reply
clan
clan Jul. 5 at 5:52 PM
$MNKD Mannkind with an advancing, productive, and prosperous pipeline... APPROVALS {and eventual accretive} ADDS TO MNKD SHARE PRICE [B4 EOY 2028]: + $4 -- acquisition of scPharma [ $SCPH ] + $4 -- label change - Afrezza + $2 -- Afrezza in India + $6 -- pediatric Afrezza + $8 -- FDA approval of Furoscix auto injector + $2 -- gestational Afrezza + $6 -- Ralinepag DPI [MNKD-1501 $UTHR ] + $7 -- Nintedanib DPI [MNKD-201] + $3 -- Bumetanide DPI [MNKD-701] + $6 -- Tyvaso DPI bridge for IPF & PPF + $? -- Undisclosed drug 👈👀😲🤑 -------- +$48/sh $SPY 👀 🇺🇲💪
0 · Reply
AXLFI_HQ
AXLFI_HQ Jul. 4 at 12:44 PM
The most recent Momentum signal on $UTHR triggered on 2026-07-02. The expected return for the selected horizon is +12.64% with a historical profit probability of +70.21%. Learn more: https://axlfi.com/factor-analysis?symbol=UTHR&factor=momentum&timeframe=daily
0 · Reply
kcphaeton
kcphaeton Jul. 2 at 5:09 PM
$MNKD $UTHR @Wolf1971 sometimes a girl needs to get her panties in a wad. Right Martine? Don’t get them in a wad.
1 · Reply
notreload_ai
notreload_ai Jul. 2 at 1:01 PM
$UTHR has acquired Thymmune Therapeutics in a $140M upfront + $160M milestone deal to advance thymus-derived cell therapies for immune disorders and organ transplantation. https://notreload.xyz/xy/united-therapeutics-acquires-thymmune-for-300m/
0 · Reply
LandonCapital
LandonCapital Jul. 2 at 12:13 PM
$UTHR https://landoncapital.net/strength-in-numbers-united-therapeutics-acquires-thymmune-for-up-to-300m/
0 · Reply
Outcomes
Outcomes Jul. 2 at 10:40 AM
$IBRX $MNKD $UTHR ......Thymus.......the 'T' in T-cell! '.......thymic cell therapies for the potential treatment of post-transplant organ tolerance, immunodeficiencies, and autoimmune diseases.' 'The clinical proof of concept and further development of THY-100 has the potential to broaden thymic regenerative medicine approaches for transplant tolerance, serious immune-mediated diseases, and enhanced longevity for older adults with diminished T-cell function.' PSS knows. Martine knows.
3 · Reply
Outcomes
Outcomes Jul. 2 at 10:37 AM
$MNKD $UTHR https://ir.unither.com/press-releases/2026/07-02-2026-113022825
0 · Reply